(Q34698767)

4 August 2017

1 reference

title

Gliclazide modified release. (English)

1 reference

4 August 2017

1 reference

2

Caroline M Perry

1 reference

4 August 2017

Jane K McGavin

1

1 reference

4 August 2017

Karen L Goa

series ordinal

3

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

62

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

1357-64; discussion 1365-6

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200262090-00010

4 August 2017

exact match

0 references

cites work

Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function

1 reference

12 December 2020

The mode of action and clinical pharmacology of gliclazide: a review

1 reference

12 December 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas

1 reference

12 December 2020

Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation

1 reference

12 December 2020

In vitro and in vivo antioxidant properties of gliclazide.

1 reference

12 December 2020

Gliclazide decreases vascular smooth muscle cell dysfunction induced by cell-mediated oxidized low-density lipoprotein.

1 reference

12 December 2020

Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells

1 reference

12 December 2020

Improving the adverse cardiovascular prognosis of type 2 diabetes

1 reference

12 December 2020

Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels

1 reference

12 December 2020

Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL

1 reference

12 December 2020

Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide.

1 reference

12 December 2020

1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.

1 reference

12 December 2020

Gliclazide: a general free radical scavenger

1 reference

12 December 2020

A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999

1 reference

12 December 2020

Structural basis for the interference between nicorandil and sulfonylurea action

1 reference

12 December 2020

Gliclazide treatment of streptozotocin diabetic rats restores GLUT4 protein content and basal glucose uptake in skeletal muscle

1 reference

12 December 2020

Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albumin

1 reference

12 December 2020

Gliclazide modified release: from once-daily administration to 24-hour blood glucose control.

1 reference

12 December 2020

Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers

1 reference

12 December 2020

Diamicron MR once daily is effective and well tolerated in type 2 diabetes: a double-blind, randomized, multinational study.

1 reference

12 December 2020

Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.

1 reference

12 December 2020

Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effect of antidiabetic medicines

1 reference

12 December 2020

Strategies for better diabetes control in the US.

1 reference

12 December 2020

Prevention of endothelial dysfunction in streptozotocin-induced diabetic rats by gliclazide treatment

1 reference

12 December 2020

Correction of glycosylated oxyhemoglobin-induced impairment of endothelium-dependent vasodilatation by gliclazide

1 reference

12 December 2020

24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily.

1 reference

12 December 2020

Gliclazide scavenges hydroxyl and superoxide radicals: an electron spin resonance study.

1 reference

12 December 2020

The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro

1 reference

12 December 2020

Effective and selective prevention of retinal leukostasis in streptozotocin-induced diabetic rats using gliclazide.

1 reference

12 December 2020

10.2165/00003495-200262090-00010

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1038833587

0 references

1 reference